Cost-Effectiveness

More from the Series

Blog Post

Sizing Up Health Commodity Markets in Low- and Middle-Income Countries: Take One

Daniel Rosen et al.
December 13, 2017
What can we say about the relative size and composition of health commodity markets across different countries? We took a stab at piecing together publicly available data sources to find an initial answer for low- and middle-income countries as part of the background work to inform the CGD Working G...
Blog Post

More Health for the Money through Better Purchasing Decisions: The Case of Ghana

November 21, 2017
Whether it’s called strategic purchasing, evidence-informed commissioning, or value-based insurance, the quest to squeeze better value out of existing resources is global. But lack of clarity regarding global and national healthcare investment goals, coupled with low technical capacity in...
CGD NOTE

Six Reasons Why the Global Fund Should Adopt Health Technology Assessment

November 08, 2017
With aid budgets shrinking and even low-income countries increasingly faced with cofinancing requirements, this is the right time for global health funders such as the Global Fund and their donors to formally introduce Health Technology Assessment (HTA), both at the central operations level and at t...